Listen Now [64:50m]: Play Now | Play in Popup | Download

The Cleantech Show #012 (MP3 - 23MB - 64min)

My guest this week is Michael Curran, a Founder and Director of Mycrolab, an Australian company developing a “Lab on a Chip” platform technology. The technology can shrink many laboratory based medical assays and diagnostic tests down to the size of a credit card and reader, by utilising microfluidic techniques.

Mycrolab’s technology is set to change the way in which diseases both in the 3rd and 1st world are treated. The developing world already has significant issues with water quality, pathogens and diseases, for which effective detection can result in better managment and isolation of potential outbreaks. As a result of climate change problems many of these issues are set to increase, with changes in disease vector migration, the potential for enviornmental refugees and the resulting health issues, and managing livestock and agricultural diseases to maintain food production.

On the show Michael and I discuss the technology itself and then go on to discuss the wider issues the world is faced with in the coming century. Currently much of the cleantech community is still operating with a view that economic benefit is equally as important as the social and environmental benefit of its labors. Michael highlights that we keep having to bring our focus back from purely a monetary outcome. That we need to identify whats wrong with the world and focus on fixing those things first.

Please make the time to listen to this show in full and let us know your thoughts in the comments.

cheers
Nick Bruse

Subscribe to TPN :: The Cleantech Show by Email - More about the host

This entry was posted on Tuesday, July 24th, 2007 at 5:37 pm and is filed under Lab on a chip, Podcast, agriculture, bird flu, clean tech, cleantech, detection, disease control, epidemics. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.